Intravenous immunoglobulin (IVIg)

In the past immunoglobulins have been used as a disease modifying treatment for multiple sclerosis in the UK, and they are still used in many other European countries. However, guidelines were published by the Department of Health in 2011 which do not recommend the use of intravenous immunoglobulin for MS, therefore they are no longer used in the UK.

Find out more

Sørensen PS, et al.
A double-blind, cross-over trial of intravenous immunoglobulin G in multiple sclerosis: preliminary results.
Multiple Sclerosis 1997;3(2):145-148.
Summary (link is external)
Department of Health.
Clinical guidelines for the use of intravenous immunoglobulin. Second edition update.
London: DH; 2011.
Full guideline (link is external)